Clinical and Histopathological Characteristics of HER2 Low-Expressing Breast Cancer

被引：0
|
作者：
Lee, Soo Hyun [1 ]
Young, Kristen [2 ]
Sofoluwe, Adeyemi [2 ]
Jacoba, Isa [1 ]
Narasimhan, Ramya [2 ]
Zhao, Qing [1 ]
Zuo, Tao [3 ]
机构：
[1] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA
[2] Boston Med Ctr, Boston, MA USA
[3] Boston Univ, Mallory Pathol Associates, Boston, MA 02215 USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
174
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [41] HER2 Low Expression in Primary Male Breast Cancer
    Nobbe, Katleen
    Erices-Leclercq, Melanie
    Foerster, Frank
    Forster, Robert
    Baldus, Stephan E.
    Rudlowski, Christian
    Schroeder, Lars
    Lubig, Sabine
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 141 - 148
  • [42] Proliferation Index in "HER2 Low" Metastatic Breast Cancer
    Hrizat, A. S.
    Brachtel, E.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S13 - S14
  • [43] Proliferation Index in "HER2 Low" Metastatic Breast Cancer
    Hrizat, A. S.
    Brachtel, E.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S13 - S14
  • [44] HER2 positivity in advanced gastric cancer:: Variation in histopathological staining compared to breast cancer
    Rueschoff, J.
    Henkel, T.
    Sloss, O.
    Bang, Y. J.
    Van Culsem, E.
    Gross, C.
    Kaufmann, M.
    MODERN PATHOLOGY, 2008, 21 : 133A - 133A
  • [45] Biological and clinical significance of HER2 overexpression in breast cancer
    Kurebayashi J.
    Breast Cancer, 2001, 8 (1) : 45 - 51
  • [46] HER2 positivity in advanced gastric cancer:: Variation in histopathological staining compared to breast cancer
    Rueschoff, J.
    Henkel, T.
    Stoss, O.
    Bang, Y. J.
    Van Cutsem, E.
    Gross, C.
    Kaufmann, M.
    LABORATORY INVESTIGATION, 2008, 88 : 133A - 133A
  • [47] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Mengdi Chen
    Weilin Chen
    Deyue Liu
    Weiguo Chen
    Kunwei Shen
    Jiayi Wu
    Li Zhu
    Breast Cancer, 2022, 29 : 844 - 853
  • [48] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Chen, Mengdi
    Chen, Weilin
    Liu, Deyue
    Chen, Weiguo
    Shen, Kunwei
    Wu, Jiayi
    Zhu, Li
    BREAST CANCER, 2022, 29 (05) : 844 - 853
  • [49] Clinical and pathological differences between HER2 Low and other cancer subtypes in breast cancer patients
    Mattar, Andre
    Amorim, Andressa
    Diogenes, Marina
    Shida, Jorge
    Gebrim, Luiz Henrique
    CANCER RESEARCH, 2023, 83 (05)
  • [50] Characteristics and clinical outcomes of patients with HER2-low breast cancer
    Koh, S.
    Koi, Y.
    Tajiri, W.
    Kawasaki, J.
    Akiyoshi, S.
    Nakamura, Y.
    Koga, C.
    Tokunaga, E.
    BREAST, 2023, 68 : S32 - S32
12345